Metabolic

Latest News

Very Low-Calorie Diet Feasible Treatment for Nonalcoholic Fatty Liver Disease

Investigators sought to determine whether a very low-calorie diet is feasible and acceptable to achieve and maintain a weight loss of 10% or more in patients with nonalcoholic fatty liver disease.

Metabolic Surgery Linked to Reduced Risk for MACE After MI

Metabolic surgery is associated with a reduced risk for major adverse cardiovascular events and death among patients with previous myocardial infarction.

Cardiac, Metabolic Morbidity Highly Prevalent in Patients With Alopecia Areata

The largest study examining the relationship between alopecia areata and cardiovascular disease in a US cohort is reviewed.

Metabolic Syndrome Linked to Worse Outcomes in COVID-19

Metabolic syndrome (MetS) is associated with a lethal outcome for patients with COVID-19.

Evidence Appears to Support Link Between Rosacea and Cardiometabolic Syndrome

Hypertension, dyslipidemia, and obesity were among the conditions investigators reviewed as being affected by the underlying inflammation associated with rosacea.

Prevalence of Metabolic Syndrome on the Rise for Some Patient Populations

The prevalence of metabolic syndrome is rising at an unequal rate among different patient demographics.

Metabolic Syndrome on the Rise Among Young Adults in the United States

The prevalence of metabolic syndrome among young adults in the United States is rising.

Unique Metabolic Signature Predicts Transition to T2D After Gestational Diabetes

Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.

Suboptimal Cardiometabolic Screening Rates for Patients With Psoriasis, Hidradenitis Suppurativa, and Atopic Dermatitis

Despite their known associations, patients with psoriasis, hidradenitis suppurativa, and atopic dermatitis are not often screened for cardiometabolic comorbidities.

How Does Gender-Affirming Hormone Treatment Affect the Metabolic Profile in Transgender Individuals?

Cross-sex hormone therapy may have a negative effect on lipid profile and glucose levels in transgender men but not in transgender women.